US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Biodelivery Sciences International (MM) (BDSIW)
Biodelivery Sciences International (MM) (BDSIW) ニュース

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BDSIW

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2005/11/08	23 : 44	Business Wire	BDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDS	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/11/01	21 : 30	Business Wire	BDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic Study	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/10/06	00 : 13	Business Wire	BDSI Closes Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/30	21 : 04	Business Wire	BDSI Prices Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/30	21 : 00	Business Wire	BDSI Prices Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/17	05 : 30	Business Wire	BDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq Independence	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/07/20	23 : 28	Business Wire	BDSI Announces Acceptance of Emezine(R) NDA for Review By FDA	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/07/19	00 : 03	Business Wire	BDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of Canc	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/06/03	20 : 00	Business Wire	BDSI Secures Additional $2.5 Million Financing With Laurus Master Fund	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/05/02	20 : 30	Business Wire	BDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and Vomiting	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2004/11/13	06 : 37	PR Newswire (US)	BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2004/04/14	01 : 00	PR Newswire (US)	BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic Sinusitis	NASDAQ:BDSIW
2004/04/06	21 : 00	PR Newswire (US)	BioDelivery Sciences International, Inc. Reports 2003 Results	NASDAQ:BDSIW	Biodelivery Sciences International (MM)

Showing the most relevant articles for your search:NASDAQ:BDSIW

1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約